Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples